Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization.

about

Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization.

Item

http://www.wikidata.org/entity/Q54356831

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Development of an easy method ...... l-color in situ hybridization.

@en

Development of an easy method ...... l-color in situ hybridization.

@nl

type

Item

label

Development of an easy method ...... l-color in situ hybridization.

@en

Development of an easy method ...... l-color in situ hybridization.

@nl

prefLabel

Development of an easy method ...... l-color in situ hybridization.

@en

Development of an easy method ...... l-color in situ hybridization.

@nl

P1476

Development of an easy method ...... l-color in situ hybridization.

@en

P2093

Futoshi Akiyama

http://www.w3.org/2001/XMLSchema#string

Rie Horii

http://www.w3.org/2001/XMLSchema#string

Takuji Iwase

http://www.w3.org/2001/XMLSchema#string

Tomoe Nakagawa

http://www.w3.org/2001/XMLSchema#string

Yoshinori Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Systematic review of HER2 breast cancer testing.

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.

Testing HER2 in breast cancer: a comparative study on BRISH, FISH, and IHC.

A UK NEQAS ISH multicenter ring study using the Ventana HER2 dual-color ISH assay.

P2888

s12282-014-0533-3

P304

78-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12282-014-0533-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24771412

http://www.w3.org/2001/XMLSchema#string